Tumaco, Colombia, is an area with elevated rates of tropical spastic paraparesis/human T-cell leukemia virus type I (HTLV-I)-associated myelopathy (TSP/HAM). We have identified a mutation in nucleotide 7959 of the tax gene of 14 Tumaco HTLV-I isolates (14 positive of 14 tested) that was present in 5 of 14 (35%) TSP/HAM patients from Japan and in 8 of 11 (72%) TSP/HAM patients from other geographic locations. In contrast, this mutation was found in only 2 of 21 (9.5%) HTLV-I-infected subjects outside of Tumaco who did not have TSP/HAM. tax clones with nucleotide mutations including one at nucleotide 7959 showed a greater ability to transactivate the HTLV-I U3 promoter. However, this effect was not observed when two clones that differed only in nucleotide 7959 were compared. These results suggest that HTLV-I-infected individuals carrying isolates with this tax mutation are at higher risk for developing TSP/HAM.
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/year, more than 100-fold higher (39) . The incidence of TSP/HAM in Tumaco is one of the highest in the world and is estimated to be 98/100,000 (32) . This high incidence rate does not appear to be the direct result of a high seroprevalence of HTLV-I, since the seroprevalence of HTLV-I is approximately 2.8% (39) .
(A part of these results was presented at the Sixth International Conference on Human Retrovirology: HTLV-I, Absecon, N.J., May 1994.)
Our initial focus was to describe HTLV-I sequences of TSP/ HAM patients from Tumaco to determine if a particular sequence(s) was present in TSP/HAM patients from Tumaco as well as TSP/HAM patients from other locations. A sequence description of a familial TSP/HAM cluster from Tumaco showed several mutations in env and tax that were not confined to Tumaco but had been described in patients with TSP/HAM from other geographic locations (31) . DNA was extracted from fresh peripheral blood lymphocytes by the proteinase K-phenol method (23) . Peripheral blood lymphocytes from an HTLV-Iseronegative individual were used as a negative control in each assay. One microgram of DNA from each sample was amplified by PCR using primers corresponding to nucleotides 7283 to 7303 and 8378 to 8356, according to the numbering of the ATK-1 clone (33) . Amplification products were electrophoresed on agarose gels and transferred to nylon membranes. Southern blot analysis was performed with internal 32 P-labeled oligonucleotide probes (nucleotides 7452 to 7272) to confirm a lack of contamination. PCR products were gel purified and cloned by a TA cloning vector system (Stratagene). Recombinant clones were selected by colony hybridization, and minipreparation DNA was used for sequencing by the dideoxynucleotide method (Sequenase). Two to three clones per patient were used for the analysis.
Nucleotide and amino acid changes in the third exon of rex did not appear to segregate with disease outcome (Table 1) . Mutations at nucleotides 7378 (threonine to isoleucine) and 7573 (arginine to histidine) were present in most Colombian isolates, supporting a geographic clustering of these HTLV-I mutations. The other mutations in rex were isolated in single patients without any geographical or disease segregation.
Sequence analysis of the third exon of tax from Tumaco TSP/HAM patients showed that only two nucleotide mutations resulted in amino acid changes (Table 1) . The mutation at nucleotide 8208 was present in some TSP/HAM patients from Colombia and Japan as well as in ATL patients from locations outside Colombia and Japan (19, 29) (Tables 1 and 2 ). The mutation at nucleotide 7959 (amino acid 221) was present in all TSP/HAM patients from Colombia and in most TSP/HAM HTLV-I clones but few ATL HTLV-I clones from other regions of the world (6, 14, 19, 21, 22, 29, 30, 33, 35, 40) . This mutation causes a valine-to-alanine amino acid change in p40 tax . It is puzzling that the tax product of an HTLV-II clone, a retrovirus not linked to TSP/HAM, also contains an alanine at this position (17) .
We also examined ATL and TSP/HAM patients and healthy carriers from Japan and Colombia. Japanese subjects were from Kyushu Island, all Colombian healthy carriers were from 
a Samples without reference numbers correspond to those done in this study. b TSP, TSP/HAM; HC, healthy carrier. c J, Japan; Co, Colombia. d Compared with the clone ATK-1 sequence indicated in the top line. Nucleotide mutations resulting in an amino acid change in Rex are underlined, those resulting in an amino acid change in Tax are italicized, and those resulting in an amino acid change in both Rex and Tax are underlined and italicized; those resulting in no amino acid change are neither italicized nor underlined. -, not done. Nucleotides are numbered according to the system of Seiki et al. (33) .
e Amino acid change(s) resulting from the nucleotide mutation. N, no change; *, stop codon.
Tumaco, and Colombian subject TSP/HAM 289 and the Colombian ATL patients were from towns near Tumaco. These samples were studied by amplifying a tax region between nucleotides 7899 and 8008. Southern blot, hybridization, and washing conditions allowed us to detect both wild-type and mutant products. Results are presented in Table 1 . In a comparison of healthy carriers from Japan and Colombia, the mutation at nucleotide 7959 is found exclusively in Colombian patients (Fisher exact test, P Ͻ 0.001). This result supports the hypothesis of a geographic distribution of mutations in HTLV-I isolates (19) . This geographic association is maintained when the presence or absence of the mutation at nucleotide 7959 in all Japanese and Colombian patients is compared independent of disease outcome (Fisher exact test, P Ͻ 0.001). Of 17 Colombian patients tested, 16 have the mutation at nucleotide 7959. Only one Colombian patient with ATL has wild-type nucleotide 7959, exclusively. Patient 2851 from Tumaco has both wild-type and mutated nucleotide 7959, showing that both types of sequences can be found in an individual. In a comparison of 29 individuals from Japan, 5 have the mutation at nucleotide 7959 and these 5 have TSP/ HAM. None of the Japanese patients with ATL have the mutation at nucleotide 7959.
To determine whether the presence or absence of the mutation at nucleotide 7959 is associated with disease outcome, we compared ATL and TSP/HAM patients from Japan and Colombia. We included in this analysis all ATL and TSP/HAM HTLV-I clones from this study as well as those from other published studies. The Fisher exact test was used for analysis of data. The mutation at nucleotide 7959 is associated with TSP/ HAM independent of geographic origin of the sample when Japanese and Colombian ATL and TSP/HAM patients are compared (P Ͻ 0.03). This association is also seen when TSP/ HAM and healthy carriers from within Japan are compared (Fisher exact test, P Ͻ 0.047). Interestingly, the only mutation in tax from TSP/HAM patient 289 that resulted in an amino acid change was at nucleotide 7959. tax nucleotide sequences of TSP/HAM and ATL patients from geographic locations other than Japan and Colombia have been reported by others (Table 2 ). When the mutation at nucleotide 7959 in these clones was analyzed, it was found that the mutation is overrepresented in TSP/HAM patients. Of six ATL patients, two (33.3%) have the mutation at nucleotide 7959. By contrast, 8 of 11 (72%) TSP/HAM patients have the mutation at nucleotide 7959.
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The p40 tax protein is a nuclear protein that plays a major role in viral regulation. It increases transcription of its own promoter in addition to increasing transcription of several cellular genes, some of which are involved in T-cell growth (2, 4, 7-9, 15, 37, 42). These Tax-responsive genes contain one of two enhancer elements that mediate Tax transactivation, NF-B and cyclic AMP response element (CRE). NF-B-containing promoters include genes such as those for interleukin-2, interleukin-2 receptor, and lymphotoxin. CRE-containing promoters include the HTLV-I long terminal repeat and cellular genes such as that for proenkephalin and c-fos.
Mutational analyses of tax have identified two separate domains responsible for transactivation of NF-B-and CREcontaining promoters (34, 36) . None of the mutations in these studies overlap with the mutation at nucleotide 7959; however, the mutation at nucleotide 7959 is located in the domain that confers NF-B transactivation. This raises the possibility that a tax gene with the mutation at nucleotide 7959 will have the ability to transactivate some promoters to a greater or lesser extent as compared with the wild-type Tax protein used in these functional studies.
To determine whether tax genes with the mutation at nucleotide 7959 transactivate the HTLV-I long terminal repeat to a 
greater extent, amplified tax from patients with (TSP/HAM 072, TSP/HAM 289, and ATL 3293) and without (ATL J3, and TSP/HAM K4) the mutation at nucleotide 7959 were cloned into the eukaryotic expression vector pZipNeoSV(X)1 (1). Chloramphenicol acetyltransferase (CAT) assays were done in Jurkat T cells using three different HTLV-I U3 CAT reporter plasmids ( Fig. 1 ; Table 3 ). tax constructs containing the mutation at nucleotide 7959 had consistently higher transactivation activity over HTLV-I U3 CAT than those without the mutation. This tendency was maintained with different HTLV-I U3 CAT constructs. Since these tax clones contain several nucleotide differences in addition to nucleotide 7959, two tax constructs that differed only at position 7959 [pZipNeoSV(X)-7959 wild type and pZipNeoSV(X)-7959 mutant] were generated. These constructs were used to test the transactivation activity on CREcontaining promoters (HTLV-I U3 CAT and c-fos CAT) and an NF-B-containing promoter (human immunodeficiency virus type 1 [HIV-1] CAT) on two cell types, Jurkat T cells and monocytic U937 cells (Table 4) . CAT assays were done in both 12-O-tetradecanoylphorbyl-13-acetate-induced and noninduced cells since an additive effect has been described between 12-O-tetradecanoylphorbyl-13-acetate and tax in inducing transactivation (28) . Both pZipNeoSV(X)-7959 wild type and pZipNeoSV(X)-7959 mutant were able to transactivate all promoters in both cell lines. In addition, 12-O-tetradecanoylphorbyl-13-acetate-induced cells showed higher CAT activity than noninduced cells. However, significant transactivation differences were not found between pZipNeoSV(X)-7959 wild type and pZipNeoSV(X)-7959 mutant in any of the cell lines when the HTLV-I U3, HIV-1 CAT, or c-fos CAT promoter was used.
Since the higher viral load seen in TSP/HAM patients could be explained by a higher transactivation of the HTLV-I long terminal repeat by tax (10, 42) , we are currently examining differences in tax mRNA or Tax protein stability that would account for the differing results with tax clones obtained directly from patients or tax with or without the mutation at nucleotide 7959 (Tables 1 and 2 ). It is still plausible that tax with the mutation at nucleotide 7959 induces or represses another type of cellular promoter that could be modified by tax.
In conclusion, we have shown that a mutation in tax nucleotide 7959 is associated with TSP/HAM disease outcome independent of the geographic origin of the patient. Whether the association of this tax mutation with TSP/HAM may be an explanation for the higher rates of TSP/HAM in Tumaco, where the mutation is present in all healthy carriers, remains to be determined. This study provides a new tool with which to study molecular events in HTLV-I infection that ultimately lead to TSP/HAM. By using Tax proteins with or without the mutation from nucleotide 7959, functional Tax phenotypes as well as the host cytotoxic T-lymphocyte and antibody immune responses to these proteins can now be determined. a All plasmids were purified by two centrifugations in CsCl equilibrium density gradients. The migration of unrestricted plasmids was analyzed on agarose gels to confirm the equal distribution of form I, II, and III DNA. Jurkat T cells were transfected by the DEAE-dextran method with 5 to 10 g of the indicated ZipNeoSV(X)1-tax construct and 2 g of reporter plasmid (13) . HTLV-I U3 CAT constructs were obtained by cloning the U3 region (nucleotides 1 to 352) in a pUC-CAT vector. Cells were harvested 48 h after transfection, and cell lysates were obtained by three freeze-thaw cycles. CAT assays were performed as described by Gorman et al. (12) with 50 to 100 g of protein.
Values correspond to percent conversion of chloramphenicol to its monodiacetylated derivatives. Plasmids were transfected into two independent cultures in two separate experiments with similar ratios of CAT activity between tax constructs. a Transfection and CAT assays in Jurkat T-cells and monocytic U937 cells were done as described in the Table 3 footnote. pZipNeoSV(X)1-7959 mutant and pZipNeoSV(X)1-7959 wild type were constructed with appropriate restriction sites. The presence or absence of the mutation at nucleotide 7959 was confirmed by sequencing the total length of tax by the dideoxynucleotide chain termination method. ϩ, cells were induced with 12-O-tetradecanoylphorbyl- 13 
